Analyst Report: LDOS

1. EXECUTIVE SUMMARY

Leidos Holdings, Inc. (NYSE: LDOS) surged 17.17% over the trading week ending August 10, 2026, closing at $139.10. This major re-rating was triggered by the company's Q2 FY2026 earnings release on August 4, which delivered a double-beat on revenues ($4.56 billion) and Non-GAAP EPS ($3.26 vs. $2.91 consensus), alongside record quarterly operating cash flow of $793 million. Driven by accelerating demand across defense technology, cybersecurity, and energy infrastructure—highlighted by a standout Defense segment book-to-bill ratio of 2.2x—management raised full-year 2026 revenue, EPS, and cash flow guidance midpoints. The combination of strong execution under the NorthStar 2030 strategy, a $48.7 billion total backlog, and a newly authorized 20-million-share buyback program has re-established institutional confidence, reversing a multi-month period of valuation compression.

2. THE CATALYST (CRITICAL)

The primary catalyst for the stock's 17.17% surge was the release of Leidos Holdings' Q2 FY2026 Financial Results and Guidance Hike, reported before the market open on Tuesday, August 4, 2026.

Key Catalyst Drivers & Financial Metrics (Q2 FY2026)

• Earnings Beat: Non-GAAP diluted EPS reached $3.26, easily beating Wall Street consensus estimates of $2.91 by $0.35 per share (+12.0% surprise).
• Revenue Outperformance: Revenue totaled $4.56 billion (+7.2% YoY, +4.0% organic), topping consensus estimates of $4.44 billion. Growth was anchored by high demand in Defense Tech (+6% organic), Energy Infrastructure, and Intelligence programs.
• Record Cash Flow Generation: Cash flow from operations reached a Q2 record of $793 million, while non-GAAP free cash flow was $761 million, significantly exceeding market expectations.
• Exceptional Defense Bookings: Net contract awards reached $5.0 billion (1.1x total book-to-bill). The Defense segment achieved a 2.2x book-to-bill ratio for the quarter (1.9x trailing 12-month average), lifting total backlog to $48.7 billion.
• Full-Year FY2026 Guidance Upgrades:
  • Revenue: Raised to $18.20B – $18.40B (midpoint $18.30B vs. $18.24B prior consensus).
  • Non-GAAP EPS: Raised to $12.20 – $12.50 (midpoint $12.35 vs. $12.34 prior consensus).
  • Operating Cash Flow: Raised to ~$1.85 billion (up from ~$1.80 billion).
• Strategic Announcements & Capital Return:
  • Board approval of a new 20-million-share repurchase authorization and declaration of a $0.43/share dividend.
  • Announcement of an over $1 billion framework agreement to supply 3,000 low-cost containerized munitions by 2030.
  • Key contract awards including Sierra Space infrared sensors for missile defense satellites, $64.8 million Office of Naval Intelligence modernization award, CoreWeave secure AI cloud partnership, and the launch of the Parcata™ cybersecurity vulnerability platform.

Timeline of the Move

Sources: Leidos Holdings Press Release (Aug 4, 2026), SEC Form 8-K (Aug 4, 2026), NYSE Trading Data (Aug 4–10, 2026).

3. COMPANY PROFILE

• Official Company Name: Leidos Holdings, Inc.
• Core Business: Leidos is a Fortune 500 science, technology, and engineering leader providing mission-critical solutions in national security, intelligence, civil threat defense, air traffic management, and health IT. Key government clients include the U.S. Department of Defense (DoD), U.S. Intelligence Community, Department of Homeland Security (DHS), Federal Aviation Administration (FAA), and Department of Veterans Affairs (VA).
• Reportable Segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems.
• Market Capitalization: ~$17.3 billion to $18.0 billion (as of August 10, 2026 close).
• Sector / Industry: Industrials / Information Technology Services & Defense Contracting.
• Key Competitors: CACI International (CACI), Science Applications International Corp (SAIC), Booz Allen Hamilton (BAH), General Dynamics (GD), L3Harris Technologies (LHX), Jacobs Solutions (J).

Recent Performance Context

Prior to the Q2 earnings release, LDOS stock was down ~23–25% YTD due to concerns over government contract award slowdowns, delays in Veterans Affairs (VA) incentive payments, and elevated acquisition integration costs. The recent surge represents a major multi-week rebound off the 52-week low.

• 52-Week Price Range: $99.25 – $205.53
• Trailing P/E Ratio: ~12.3x (significantly below historic sector peer averages)

4. DEEP DIVE ANALYSIS

Fundamental Justification vs. Overreaction

The +17.17% weekly surge is fully justified by fundamentals rather than speculative momentum:

1. Cash Flow Multiplier: Generating $761 million in free cash flow in a single quarter for a $17B market cap firm provides tangible balance sheet firepower to fund debt reduction, R&D, and share buybacks.
2. Backlog Visibility: A 2.2x Defense book-to-bill and a total backlog of $48.7 billion effectively de-risks revenue projections into FY2027 and beyond.
3. Valuation Reset: Prior to earnings, LDOS traded near ~11x forward earnings. The earnings beat and updated guidance forced short-sellers to cover and value investors to aggressively re-enter.

Sector Dynamics & Competitor Comparison

While broader defense contractors have seen modest gains from expanded DoD outlays, Leidos outperformed peers (SAIC, BAH, CACI) in Q2 due to its exposure to high-priority growth pillars: hypersonic missile tracking, autonomous marine systems, cybersecurity (Parcata), and cloud-native AI infrastructure (CoreWeave alliance).

Q2 Performance Metrics Comparison (LDOS vs. Peers)
-----------------------------------------------------------------------
Metric                         Leidos (LDOS)     CACI / SAIC Peer Avg
-----------------------------------------------------------------------
Revenue YoY Growth                 +7.2%                +4.5% - 5.5%
Defense Book-to-Bill                2.2x                  1.2x - 1.4x
Q2 Free Cash Flow                 $761M                 $180M - $250M
FY2026 Guidance Change           Raised                 Maintained
-----------------------------------------------------------------------

Bull vs. Bear Case Analysis

Bull Case

• NorthStar 2030 Pivot: Successful transition from lower-margin IT maintenance to high-value mission integration, AI software platforms, and missile/drone defense production.
• Capital Return Support: The new 20-million-share buyback program signals management's view that equity remains undervalued, providing downside price protection.
• Production Conversion: Transitioning major development programs (e.g., Navy Medium Unmanned Surface Vessels, low-cost containerized munitions) into multi-year production awards.

Bear Case

• VA Managed Health Drag: The VA suspended vendor incentive payments for the remainder of 2026, posing a margin headwind in the Health & Civil segment.
• Government Insourcing Pressure: Trends toward Federal clients taking certain systems integration tasks in-house (e.g., MHS Genesis support updates).
• Budget Delays: Exposure to U.S. Congressional fiscal budget friction and Continuing Resolutions (CRs) heading into FY2027.

5. TECHNICAL SNAPSHOT

Price Chart Snapshot (Aug 3 - Aug 10, 2026)
$141.00 |                                                 * ($139.10)
$136.00 |                                            *  * 
$131.00 |                          * 
$126.00 |                     *         *
$121.00 |
$116.00 |  *
        +-------------------------------------------------------------
          Aug 3      Aug 4      Aug 5     Aug 6    Aug 7   Aug 10

• Current Price: $139.10 (as of August 10, 2026 close)
• Moving Averages:
  • 5-Day SMA: $133.88 (Bullish / Upward Crossover)
  • 50-Day SMA: ~$124.10
  • 200-Day SMA: ~$144.74 (Key macro overhead resistance)
• Momentum Indicators:
  • 14-Day RSI: 74.05 (Overbought territory, reflecting strong buying momentum following earnings).
  • MACD (12,26,9): Bullish histogram expansion (+3.93 to +5.35).
• Key Technical Levels:
  • Immediate Support: $135.00 (Aug 6 breakout base), $130.60 (Aug 4 gap-up close).
  • Major Support: $126.50 – $127.00 (50-day SMA & Aug 5 pull-back low).
  • Immediate Resistance: $140.90 – $141.00 (Aug 10 intraday high).
  • Major Resistance: $144.75 – $145.00 (200-day Simple Moving Average).

6. RISK FACTORS

1. Short-Term Technical Overextension: With RSI at ~74, LDOS is technically overbought, creating potential for minor near-term profit taking toward the $132–$135 support zone.
2. Administrative VA Suspensions: Vendor incentive payment freezes by the Department of Veterans Affairs could press Health & Civil margins if extended past FY2026.
3. Macro Defense Budget Delays: Prolonged Continuing Resolutions (CRs) in Washington could delay contract obligational authority for new defense tech programs.
4. Upcoming Catalysts to Monitor:

• Late September 2026: Dividend Ex-Date ($0.43/share).
• Q4 2026: Targeted award announcement for U.S. Navy Medium Unmanned Surface Vessel production contract.
• Late October / Early November 2026: Q3 FY2026 Earnings Release.

7. ACTIONABLE OUTLOOK

Short-Term (1–2 Weeks)

• Target Range: $135.00 – $142.00
• Expectation: Consolidation around the $137–$140 price level as the market digests the initial earnings gap. High-volume institutional support around $132–$135 represents an attractive tactical re-entry point for long position building.

Medium-Term (1–3 Months)

• Target Range: $148.00 – $155.00
• Drivers: Analyst target price revisions (consensus recently raised to $153.47), execution of share repurchases under the new 20M share authorization, and anticipated Q4 defense program production decisions. Breaking above the 200-day SMA ($144.74) will trigger additional algorithmic buying.

Long-Term Thesis

• Status: FUNDAMENTALLY STRENGTHENED
• Conclusion: Leidos has successfully proven that its NorthStar 2030 pivot toward AI, cybersecurity, and advanced defense hardware is bearing fruit. Supported by a $48.7 billion backlog and industry-leading cash conversion, LDOS remains a high-conviction core holding in defense technology.